Chitosan-Assisted Immunotherapy for Intervention of Experimental Leishmaniasis via Amphotericin B-Loaded Solid Lipid Nanoparticles

Applied Biochemistry and Biotechnology

Volumn 174, Issue 4, 2014, Pages 1309-1330

  Jain, Vineet ^a   Gupta, Annie ^a   Pawar, Vivek K ^a   Asthana, Shalini ^a   Jaiswal, Anil K ^a   Dube, Anuradha ^a   Chourasia, Manish K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Amphotericin B; Chitosan; Cytokine; Immunotherapy; Leishmaniasis; Nanomedicine; Toxicity

Indexed keywords

CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DISEASE CONTROL; EMULSIFICATION; IMMUNE SYSTEM; MACROPHAGES; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; PARTICLE SIZE; TOXICITY;

AMPHOTERICIN B; CYTOKINES; DRUG DELIVERY SYSTEM; IMMUNOTHERAPY; LEISHMANIASIS; POLYMERIC NANOPARTICLES; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES;

CHITOSAN;

AMPHOTERICIN B; ANTIPROTOZOAL AGENT; CHITOSAN; EMULSION; LIPID; NANOPARTICLE;

ANIMAL; CELL LINE; CHEMISTRY; EMULSION; IMMUNOLOGY; IMMUNOTHERAPY; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MOUSE; PATHOLOGY; PHARMACOLOGY;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; CHITOSAN; EMULSIONS; IMMUNOTHERAPY; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPIDS; MICE; NANOPARTICLES;

EID: 84929462985     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-014-1084-y     Document Type: Article

References (44)

1. Strazzulla, A., Cocuzza, S., Pinzone, M. R., Postorino, M. C., Cosentino, S., Serra, A., Cacopardo, B., & Nunnari, G. (2013). Mucosal leishmaniasis: an underestimated presentation of a neglected disease. BioMed Research International, 2013, 805108.
2. Awasthi, A., Mathur, R. K., & Saha, B. (2004). Immune response to Leishmania infection. The Indian Journal of Medical Research, 119, 238–258.
3. Murray, H. W., Berman, J. D., Davies, C. R., & Saravia, N. G. (2005). Advances in leishmaniasis. Lancet, 366, 1561–1577.
4. Van Assche, T., Deschacht, M., da Luz, R. A., Maes, L., & Cos, P. (2011). Leishmania-macrophage interactions: insights into the redox biology. Free Radical Biology, 51, 337–351.
5. Baginski, M., & Czub, J. (2009). Amphotericin B and its new derivatives—mode of action. Current Drug Metabolism, 10, 459–469.
6. Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003). Antifungal agents: mechanisms of action. Trends in Microbiology, 11, 272–279.
7. Neumann, A., Baginski, M., & Czub, J. (2010). How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets. Journal of the American Chemical Society, 132, 18266–18272.
8. Czub, J., Borowski, E., & Baginski, M. (2007). Interactions of amphotericin B derivatives with lipid membranes—a molecular dynamics study. Biochimica et Biophysica, 1768, 2616–2626.
9. Brajtburg, J., Powderly, W. G., Kobayashi, G. S., & Medoff, G. (1990). Amphotericin B: current understanding of mechanisms of action. Antimicrobial Agents and Chemotherapy, 34, 183–188.
10. Jain, S., Valvi, P. U., Swarnakar, N. K., & Thanki, K. (2012). Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Molecular Pharmaceutics, 9, 2542–2553.
11. Pham, T. T. H., Loiseau, P. M., & Barratt, G. (2013). Strategies for the design of orally bioavailable antileishmanial treatments. International Journal of Pharmaceutics, 454, 539–552.
12. Patel, P. A., & Patravale, V. B. (2011). AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. Journal of Biomedical Nanotechnology, 7, 632–639.
13. Jain, S. K., Chourasia, M. K., Masuriha, R., Soni, V., Jain, A., Jain, N. K., & Gupta, Y. (2005). Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Delivery, 12, 207–215.
14. Kipp, J. E. (2004). The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. International Journal of Pharmaceutics, 284, 109–122.
15. Severino, P., Andreani, T., Macedo, A. S., Fangueiro, J. F., Santana, M. H., Silva, A. M., & Souto, E. B. (2012). Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. Journal of Drug Delivery, 2012, 750891.
16. Jung, S. H., Lim, D. H., Jung, S. H., Lee, J. E., Jeong, K.-S., Seong, H., & Shin, B. C. (2009). Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics. European Journal of Pharmaceutical Sciences, 37, 313–320.
17. Ma, Z. X., & Zhao, L. H. (2011). Polysaccharides activate signaling pathways of macrophage. Zhejiang Da Xue Xue Bao. Yi Xue Ban, 40, 567–572.
18. Ahsan, F., Rivas, I. P., Khan, M. A., & Torres Suárez, A. I. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. Journal of Controlled Release, 79, 29–40.
19. Li, G., Liu, Z., Liao, B., & Zhong, N. (2009). Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cellular & Molecular Immunology, 6, 45–50.
20. Asthana, S., Jaiswal, A. K., Gupta, P. K., Pawar, V. K., Dube, A., & Chourasia, M. K. (2013). Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B encapsulated nano-emulsion template based chitosan nanocapsules. Antimicrobial Agents and Chemotherapy, 57, 1714–1722.
21. Kunjachan, S., Gupta, S., Dwivedi, A. K., Dube, A., & Chourasia, M. K. (2011). Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis. Journal of Microencapsulation, 28, 301–310.
22. Venkateswarlu, V., & Manjunath, K. (2004). Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. Journal of Controlled Release, 95, 627–638.
23. Vauthier, C., & Bouchemal, K. (2009). Methods for the preparation and manufacture of polymeric nanoparticles. Pharmaceutical Research, 26, 1025–1058.
24. Silva, C., Ribeiro, A., Figueiredo, M., Ferreira, D., & Veiga, F. (2005). Microencapsulation of hemoglobin in chitosan-coated alginate microspheres prepared by emulsification/internal gelation. The AAPS Journal, 7, E903–E913.
25. Zhang, L., Liu, L., Qian, Y., & Chen, Y. (2008). The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). European Journal of Pharmaceutics and Biopharmaceutics, 69, 750–759.
26. Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994). Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. Journal of Controlled Release, 30, 83–96.
27. Chourasia, M. K., Kang, L., & Chan, S. Y. (2011). Nanosized ethosomes bearing ketoprofen for improved transdermal delivery. Results in Pharma Sciences, 1, 60–67.
28. Nishi, K. K., Antony, M., Mohanan, P. V., Anilkumar, T. V., Loiseau, P. M., & Jayakrishnan, A. (2007). Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi. Pharmaceutical Research, 24, 971–980.
29. Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999). Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. Journal of Controlled Release, 59, 299–307.
30. Singh, P., Gupta, A., Jaiswal, A., Dube, A., Mishra, S., & Chaurasia, M. K. (2011). Design and development of amphotericin B bearing polycaprolactone microparticles for macrophage targeting. Journal of Biomedical Nanotechnology, 7, 50–51.
31. Elcicek, S., Bagirova, M., & Allahverdiyev, A. M. (2013). Generation of avirulent Leishmania parasites and induction of nitric oxide production in macrophages by using polyacrylic acid. Experimental Parasitology, 133, 237–242.
32. Jain, N. K., Mishra, V., & Mehra, N. K. (2013). Targeted drug delivery to macrophages. Expert Opinion on Drug Delivery, 10, 353–367.
33. Zaharoff, D. A., Rogers, C. J., Hance, K. W., Schlom, J., & Greiner, J. W. (2007). Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine, 25, 2085–2094.
34. Brajtburg, J., Elberg, S., Schwartz, D. R., Vertut-Croquin, A., Schlessinger, D., Kobayashi, G. S., & Medoff, G. (1985). Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B. Antimicrobial Agents and Chemotherapy, 27, 172–176.
35. Takahashi, H., Niidome, Y., Niidome, T., Kaneko, K., Kawasaki, H., & Yamada, S. (2005). Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir, 22, 2–5.
36. VandeVord, P. J., Matthew, H. W. T., DeSilva, S. P., Mayton, L., Wu, B., & Wooley, P. H. (2002). Evaluation of the biocompatibility of a chitosan scaffold in mice. Journal of Biomedical Materials Research, 59, 585–590.
37. Mori, T., Murakami, M., Okumura, M., Kadosawa, T., Uede, T., & Fujinaga, T. (2005). Mechanism of macrophage activation by chitin derivatives. The Journal of Veterinary Medical Science, 67, 51–56.
38. Basu, N., Sett, R., & Das, P. K. (1991). Down-regulation of mannose receptors on macrophages after infection with Leishmania donovani. The Biochemical Journal, 277, 451–456.
39. Legrand, P., Vertut-Doi, A., & Bolard, J. (1996). Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line. The Journal of Antimicrobial Chemotherapy, 37, 519–533.
40. Privé, C., & Descoteaux, A. (2000). Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. European Journal of Immunology, 30, 2235–2244.
41. Yang, Z., Mosser, D. M., & Zhang, X. (2007). Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. The Journal of Immunology, 178, 1077–1085.
42. Nandan, D., & Reiner, N. E. (1995). Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infection and Immunity, 63, 4495–4500.
43. Chen, C.-L., Wang, Y.-M., Liu, C.-F., & Wang, J.-Y. (2008). The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials, 29, 2173–2182.
44. Barwicz, J., Christian, S., & Gruda, I. (1992). Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrobial Agents and Chemotherapy, 36, 2310–2315.